FOCUS OF THE STUDY: SAFETY OF XFB19

Clinical trials for FOCUS OF THE STUDY: SAFETY OF XFB19 explained in plain language.

Never miss a new study

Get alerted when new FOCUS OF THE STUDY: SAFETY OF XFB19 trials appear

Sign up with your email to follow new studies for FOCUS OF THE STUDY: SAFETY OF XFB19, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug XFB19 takes first step: safety check in healthy people

Knowledge-focused Recruiting now

This early-stage study is the first time the experimental drug XFB19 is being tested in humans. The main goal is to check its safety in 40 healthy adults aged 18 to 55. Participants will receive either the drug or a placebo, and researchers will monitor for side effects and how t…

Matched conditions: FOCUS OF THE STUDY: SAFETY OF XFB19

Phase: PHASE1 • Sponsor: Xfibra, Inc. • Aim: Knowledge-focused

Last updated May 19, 2026 11:48 UTC

FOCUS OF THE STUDY: SAFETY OF XFB19

Get alerted when new FOCUS OF THE STUDY: SAFETY OF XFB19 trials appear

New drug XFB19 takes first step: safety check in healthy people